SCHEMBL1123867

SCHEMBL1123867

Nc1c(N2CCOCC2)nc(C=Cc2ccc(F)cc2)nc1N1CCOCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.45
FLT3 P36888 2/20 0.44
CTSK P43235 2/20 0.43
KDM4E B2RXH2 2/20 0.41
LMNA P02545 2/20 0.41
ALDH1A1 P00352 1/20 0.41
PRKDC P78527 1/20 0.41
PIK3CA P42336 1/20 0.40
GRIA1 P42261 1/20 0.40
CACNG2 Q9Y698 1/20 0.40
STK4 Q13043 1/20 0.40
STK3 Q13188 1/20 0.40
LRRK2 Q5S007 1/20 0.40
TP53 P04637 2/20 0.39
NPC1 O15118 1/20 0.39
AR P10275 1/20 0.39
RAB9A P51151 1/20 0.39
HTT P42858 1/20 0.39
GAA P10253 1/20 0.39
MEN1 O00255 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1123866 1.00 MAPT (0.45) MAPTFLT3CTSKKDM4ELMNA
SCHEMBL1123760 0.85 CTSK (0.43) MAPTCTSKKDM4ELMNAALDH1A1
SCHEMBL1123986 0.85 CTSK (0.43) MAPTCTSKKDM4ELMNAALDH1A1
SCHEMBL1124042 0.84 CTSK (0.52) MAPTCTSKKDM4ELMNAALDH1A1
SCHEMBL1124056 0.84 CTSK (0.52) MAPTCTSKKDM4ELMNAALDH1A1
SCHEMBL1123930 0.83 FLT3 (0.47) MAPTFLT3KDM4EPIK3CANPC1
SCHEMBL1123926 0.83 FLT3 (0.47) MAPTFLT3KDM4EPIK3CANPC1
SCHEMBL1123794 0.78 HRH4 (0.46) MAPTFLT3KDM4E
SCHEMBL1123790 0.78 HRH4 (0.46) MAPTFLT3KDM4E
SCHEMBL1123917 0.78 FLT3 (0.45) MAPTFLT3KDM4EPIK3CANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8563715-B2 Pyrimidine derivative having cell protecting effect and uses thereof ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2013-10-22 US claimed
EP-2284160-B1 PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF ZENYAKU KOGYO KK (JP) 2013-05-15 EP claimed
US-20110152519-A1 PYRIMIDINE DERIVATIVE HAVING CELL PROTECTING EFFECT AND USES THEREOF ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2011-06-23 US claimed
EP-2284160-A1 PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2011-02-16 EP claimed
US-8563715-B2 Pyrimidine derivative having cell protecting effect and uses thereof ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2013-10-22 US disclosed
EP-2284160-B1 PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF ZENYAKU KOGYO KK (JP) 2013-05-15 EP disclosed
US-20110152519-A1 PYRIMIDINE DERIVATIVE HAVING CELL PROTECTING EFFECT AND USES THEREOF ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2011-06-23 US disclosed
EP-2284160-A1 PYRIMIDINE DERIVATIVE HAVING CELL-PROTECTING ACTIVITY AND USE THEREOF ZENYAKU KOGYO KABUSHIKIKAISHA (JP) 2011-02-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110152519-A1 PYRIMIDINE DERIVATIVE HAVING CELL PROTECTING EFFECT AND USES THEREOF CASP3, DPYD, CASP1 MAPT 350/4885FLT3 3375/4885CTSK 2876/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.